About Access Genomics
Access Genomics is a Healthcare company based in Mississauga (Canada) founded in 2016, and was acquired by Igenomix in December 2020. Diagnostic tests for clinical genomic solutions are provided. The company was acqui-hired. Its focus areas include Life Sciences, Women Health, In Vitro Diagnostic Tests and Diversified.
Company details
Access Genomics was founded in 2016 and is based in Mississauga, Canada. Operations focus on the genomics sector, where services in molecular biology, embryology, and diagnostic screening are offered. Products include Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Non-Invasive Prenatal Testing (NIPT) for detecting trisomies 21, 18, and 13, as well as select sex chromosome aneuploidies. Genetic counselling services are also provided to support clinical applications.
- Headquarters Mississauga, Canada
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website accessgenomics.ca
- Social LinkedIn
- Acquired by Igenomix (Dec 2020)
Investors in Access Genomics
Access Genomics has secured backing from 1 investor. Prominent investors backing the company include Igenomix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Reproductive genetic testing services are provided by the medical laboratory. | 2009 | igenomix.com | Paterna, Spain |
Investor details for Access Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Access Genomics
2 dated milestones of Access Genomics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Access Genomics is founded.
- Exit Acquired by Igenomix.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Access Genomics
Complete news archive for Access Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Access Genomics
Access Genomics was founded in 2016.
Access Genomics is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Access Genomics was founded in 2016 and is based in Mississauga, Canada. Operations focus on the genomics sector, where services in molecular biology, embryology, and diagnostic screening are offered. Products include Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Non-Invasive Prenatal Testing (NIPT) for detecting trisomies 21, 18, and 13, as well as select sex chromosome aneuploidies. Genetic counselling services are also provided to support clinical applications.
Access Genomics has 1 investor. Key investors include Igenomix.
Yes. Access Genomics was acquired by Igenomix in December 2020.